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Problem Identification and Need
Tick encounters and Tick-borne diseases are increasing in prevalence in Vermont
•

Research suggests that around 300,000 people are diagnosed with Lyme
disease each year.

•

Tick encounters have been well above the historic average this year with some
weeks being above the historic maximum in Vermont.

•

In 2016 Vermont was one of 14 states that contributed to 95% of confirmed
Lyme disease cases.

•

Vermont has the highest average incidence of Lyme disease per 100,000
persons in the United States.

The Blacklegged tick is responsible for more than 99% of all tickborne diseases
reported in Vermont.
•

52.9% carry Borrelia burgdorferi, 7% carry Anaplasma phagocytophilum, and
0.8% carry Babesia microti.

Changing landscape of tickborne diseases:

•

In 2008 Lyme disease contributed 97% of tickborne disease with anaplasmosis,
babesiosis and erlichosis contributing 1% each in the state of VT.

•

In 2016 Lyme disease contributed 77% of tickborne disease while
anaplasmosis contributed 21% and Babesiosis 2% in the state of VT.

Problem Identification and Need
Patient awareness of tickborne diseases is lacking:
•

In the New England and Mid-Atlantic regions, areas that have a high
incidence of Lyme disease, Anaplasmosis and Babesiosis, 13.9% of those
surveyed reported that no tickborne diseases occur in their area and
20.8% said they had not heard of any of these diseases.

•

Regardless of region few respondents reported that the following
diseases occur where they live: Anaplasmosis (0.9%), Babesiosis (1.1%).

•

21.0% of total respondents reported that a household member found a
tick on his or her body during the previous year; of these, only 10.1%
reported that a health care provider was consulted as a result of finding
a tick on a household member

•

The majority of respondents (51.2%) reported that they did not
routinely take any personal prevention steps against tick bites during
warmer weather seasons.

From provider perspective (what can they do for chronic disease):
•

The Centers for Disease Control and Prevention estimates 10 to 20
percent of those treated for Lyme disease with the recommended twoto-four week course of antibiotics continue to have symptoms.

•

There is no approved therapy for these patients and the magnitude of
the problem in the U.S. population has never been systematically
studied.

Anaplasmosis cases in VT in 2008 and 2015

Public Health Cost and Unique Cost
Considerations
Healthcare costs:
•

Lyme disease costs the U.S. health care system between $712 million and $1.3 billion a year

•

Lyme disease is associated with $2,968 higher total health care costs over a 12-month period,
as compared to a control group.

•

Lyme disease is associated with 87% higher evaluation and management visits and 71% higher
emergency department visits over a 12-month period, relative to a control group.

•

Among those who were diagnosed with Lyme disease, having one or more symptoms of post
treatment Lyme disease syndrome was associated with $3,798 more in health care costs as
compared to those with no post-treatment symptoms.

There is a fear of going outside due to the prevalence of tickborne diseases:

•

Researchers found that the perceived risks of contracting Lyme disease, on average, cause a
person in the Northeast to forego eight 73-minute outdoor trips per year, which results to
about nine hours of outdoor time per year.

•

"People are giving up trips, and it's not just hiking and camping in the woods," said Kevin Berry,
a former postdoctoral scholar at F&ES and the lead author of the study ‘The Allocation of Time
and Risk of Lyme’. "It's trips to the park, soccer games, or walks and bike rides in places where
there are stands of trees and tall grasses... a wide variety of activities pretty much anywhere in
this part of the Northeast that's outdoors.“

•

Eli Fenichel, an assistant professor at the Yale School of Forestry & Environmental Studies
(F&ES) and senior author of the study ‘The Allocation of Time and Risk of Lyme’ mentioned
that Lyme disease has been very expensive, but “the cost is not what people spend on doctors,
or medicine, or even bug spray. These are costs that everybody incurs because we’re all
choosing second-choice activities to avoid getting Lyme disease.”

•

The study found that people in the northeastern United States will make 1 billion fewer trips to
the outdoors like hiking in the woods or trips to parks resulting in approximately $2.8 billion to
$5 billion in lost revenue every year.

Community Perspective
Jennifer Overton (Washington county resident)
• Students are learning extensively about ticks
and tickborne diseases in high school biology
class. This has helped make community
members more aware and knowledgeable
about this topic.
• If a vaccine was available to prevent
tickborne diseases it would definitely be
supported.
• There have been moments where tall grass
has been avoided due to the fear of ticks.
• Have thought about different methods to
help combat ticks in the surrounding area
including the possibility of getting a guinea
hen.

CVMC Community Health Team
• Would like to see improvement in
treatment strategies especially for
patients that do not have symptoms
resolved after the typical course of
antibiotics.
• Would like to see improvement in the
quality of testing for tickbrone diseases
as the sensitivity and specificity for some
of the tests are not that high.
• Would like to more information about
the successes that naturopaths have had
with patients with symptoms persisting
after original course of treatment.

Intervention and
Methodology
Create an educational handout for both
patients and providers:
- For patients: focuses on tick bite
prevention strategies, proper tick removal
and major signs and symptoms of tickborne
illness. This is intended to be offered to all
patients entering the office as there are
many useful prevention techniques as well
as more specifically to be handed out to
patients with concern for tickborne disease.
- For providers: focuses on identification
of ticks, signs and symptoms, pertinent lab
tests and results, diagnostic testing and
treatment. Also contains a quick reference
guide that contains the most pertinent
information healthcare providers will need
to efficiently and correctly make the proper
diagnosis and apply appropriate treatment.

Results
• An educational handout was
created for both patients and
healthcare providers. There
was also a quick reference
guide created in a table format
that contains the pertinent
information about the major
tickborne diseases in Vermont.
• Educational materials were
provided to the Berlin Family
Medicine Practice to be
distributed to both patients
and healthcare providers.

Evaluation of Effectiveness
and Limitations
Evaluation of Effectiveness
•

Need to deliver more handouts to patients and providers before effectiveness of the handout can be
determined. Survey is likely the best method of monitoring its effectiveness.

•

Can survey patients that received a handout to see if they were more likely to use the prevention
strategies mentioned in the handout.

•

Can survey patients to see if they were better able to identify the signs and symptoms of a tickborne
illness in order to receive earlier treatment prior to progression of the disease.

•

Can survey providers to see if they were able to more quickly identify, diagnose and appropriately treat
tickborne disease using the quick reference guide.

Limitations:
•

Only reaching a small portion of the state via CVMC as not everyone regularly sees a healthcare
provider.

•

Not everyone will read the educational material even if they receive it.

•

Not everyone will act on the information they acquire to protect themselves.

•

There likely is not enough time for a provider to fully discuss with a patient all of the information in the
handout given the time constraints of a typical visit. This would likely be the most effective way for
change to happen.

•

There is an evolving landscape of tickborne illnesses that may potentiate new risks to patients that are
currently unfound.

•

As long as there are ticks or another vector to harbor these diseases that can subsequently inject it into
a human, there will always be a risk for infection.

Lyme disease cases in VT in 2008 and 2015

Recommendations for Future
Interventions/Projects
• Working with other hospitals and community centers to ensure that they have educational materials
available to members of the community on tickborne diseases and prevention strategies.
• Creating a new position as part of the community health team to discuss tickborne diseases with patients or
educate current community health team members to incorporate this into their role. This could include
discussing the handout with patients.
• Educating our youth by having a presentation on tickborne diseases at each of the schools around Vermont.
• Educating the community by holding presentations at large public event centers.
• Look into more effective ways to treat patients who are still suffering from the disease after the initial course
of treatment.
• Look more into the possibility for and effectiveness of prophylactic antibiotics for people that are at a higher
risk for exposure.
• Continue research into improving diagnostic testing for tickborne diseases.
• Continue research for tickborne disease vaccines.
• Researching the ecology and population genetics of ticks to find an environmentally friendly way to reduce
the tick population.
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